FDA Inspection
Lymol Medical CorporationLymol Medical Corporation – FDA Inspection, Dec 15, 2011
Record Details
This FDA Inspection record concerns Lymol Medical Corporation, with an inspection on December 15, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lymol Medical Corporation
- Inspection Date
- December 15, 2011
- Product Type
- Drugs
View Company Profile
ID · 2fd9cd61-e505-425a-9629-ff1098fcd397
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 759069
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
FDA Citations
2- 21 CFR 314.80(c)(2)Late submission of annual safety reports
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lymol Medical Corporation
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 29, 2021 | OAI | Center for Devices and Radiological Health | Compliance: Devices |
| February 12, 2020 | OAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 24, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 14, 2010 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| July 9, 2009 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Lymol Medical Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.